Marin County biotech Ultragenyx reports $151 million Q4 loss
The Marin County-based maker of treatments for rare chronic diseases on Thursday reported bigger quarterly and annual losses than a year before.
The Marin County-based maker of treatments for rare chronic diseases on Thursday reported bigger quarterly and annual losses than a year before.
Based on recent headline ratings, 80% of this readership currently trusts the local media, which has an average score of 91% regionally and is currently trending negative.